GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (STU:9OM1) » Definitions » Cyclically Adjusted Price-to-FCF

EXMceuticals (STU:9OM1) Cyclically Adjusted Price-to-FCF : (As of May. 24, 2024)


View and export this data going back to 2019. Start your Free Trial

What is EXMceuticals Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


EXMceuticals Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for EXMceuticals's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Cyclically Adjusted Price-to-FCF Chart

EXMceuticals Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EXMceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of EXMceuticals's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, EXMceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EXMceuticals's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EXMceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where EXMceuticals's Cyclically Adjusted Price-to-FCF falls into.



EXMceuticals Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

EXMceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2021 is calculated as:

For example, EXMceuticals's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2021 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2021 (Change)*Current CPI (Mar. 2021)
=-0.003/110.2976*110.2976
=-0.003

Current CPI (Mar. 2021) = 110.2976.

EXMceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201106 -0.017 94.654 -0.020
201109 0.007 95.286 0.008
201112 -0.009 94.970 -0.010
201203 -0.004 96.155 -0.005
201206 -0.004 96.076 -0.005
201209 -0.003 96.392 -0.003
201212 -0.006 95.760 -0.007
201303 -0.004 97.103 -0.005
201306 -0.003 97.182 -0.003
201309 -0.005 97.419 -0.006
201312 -0.005 96.945 -0.006
201403 -0.003 98.604 -0.003
201406 -0.007 99.473 -0.008
201409 -0.003 99.394 -0.003
201412 -0.017 98.367 -0.019
201503 0.000 99.789 0.000
201506 -0.001 100.500 -0.001
201509 -0.001 100.421 -0.001
201512 -0.007 99.947 -0.008
201603 -0.014 101.054 -0.015
201606 -0.010 102.002 -0.011
201609 -0.002 101.765 -0.002
201612 -0.001 101.449 -0.001
201703 -0.001 102.634 -0.001
201706 0.000 103.029 0.000
201709 -0.002 103.345 -0.002
201712 -0.006 103.345 -0.006
201803 -0.004 105.004 -0.004
201806 -0.002 105.557 -0.002
201809 -0.017 105.636 -0.018
201812 -0.049 105.399 -0.051
201903 -0.016 106.979 -0.016
201906 -0.032 107.690 -0.033
201909 -0.022 107.611 -0.023
201912 -0.024 107.769 -0.025
202003 -0.037 107.927 -0.038
202006 0.006 108.401 0.006
202009 -0.007 108.164 -0.007
202012 -0.003 108.559 -0.003
202103 -0.003 110.298 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


EXMceuticals  (STU:9OM1) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


EXMceuticals Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


EXMceuticals (STU:9OM1) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (STU:9OM1) Headlines

No Headlines